Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression.

Ottaviani S, Stebbing J, Frampton AE, Zagorac S, Krell J, de Giorgio A, Trabulo SM, Nguyen VTM, Magnani L, Feng H, Giovannetti E, Funel N, Gress TM, Jiao LR, Lombardo Y, Lemoine NR, Heeschen C, Castellano L.

Nat Commun. 2019 Aug 14;10(1):3738. doi: 10.1038/s41467-019-11752-2.

2.

Circulating MicroRNAs in Small-bowel Neuroendocrine Tumors: A Potential Tool for Diagnosis and Assessment of Effectiveness of Surgical Resection.

Malczewska A, Frampton AE, Mato Prado M, Ameri S, Dabrowska AF, Zagorac S, Clift AK, Kos-Kudła B, Faiz O, Stebbing J, Castellano L, Frilling A.

Ann Surg. 2019 Aug 1. doi: 10.1097/SLA.0000000000003502. [Epub ahead of print]

PMID:
31373926
3.

Invited Commentary: ACCESS Open Minds National Youth Council.

Tan J, Bernard B, Chung J, Debbouz MA, Fehr V, Frampton A, Jalali S, McLean HM, Poukhovski-Sheremetyev F, Saunders E, Thomas L, Viens-Maranda J, Mireault C.

Early Interv Psychiatry. 2019 Jun;13 Suppl 1:65-67. doi: 10.1111/eip.12820. No abstract available.

PMID:
31243910
4.

Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?

Liu DSK, Mato Prado M, Giovannetti E, Jiao LR, Krell J, Frampton AE.

Expert Rev Mol Diagn. 2019 Jul;19(7):553-558. doi: 10.1080/14737159.2019.1622414. Epub 2019 Jun 10. No abstract available.

PMID:
31159604
5.

Pharmacogenetics of treatments for pancreatic cancer.

El Hassouni B, Li Petri G, Liu DSK, Cascioferro S, Parrino B, Hassan W, Diana P, Ali A, Frampton AE, Giovannetti E.

Expert Opin Drug Metab Toxicol. 2019 Jun;15(6):437-447. doi: 10.1080/17425255.2019.1620731. Epub 2019 May 24. Review.

PMID:
31100206
6.

Marked Biatrial Calcification in Long-Term Haemodialysis.

Appadurai V, Burke MT, Frampton A, Nicolae M.

Heart Lung Circ. 2019 Jul;28(7):e117-e118. doi: 10.1016/j.hlc.2019.01.016. Epub 2019 Feb 26. No abstract available.

PMID:
30853524
7.

Rapid Induction of Liver Regeneration for Major Hepatectomy (REBIRTH): A Randomized Controlled Trial of Portal Vein Embolisation versus ALPPS Assisted with Radiofrequency.

Jiao LR, Fajardo Puerta AB, Gall TMH, Sodergren MH, Frampton AE, Pencavel T, Nagendran M, Habib NA, Darzi A, Pai M, Thomas R, Tait P.

Cancers (Basel). 2019 Mar 4;11(3). pii: E302. doi: 10.3390/cancers11030302.

8.

Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?

Gall TMH, Gerrard G, Frampton AE, Castellano L, Ahmad R, Habib N, Spalding D, Pai M, Foroni L, Jiao LR.

Oncotarget. 2019 Jan 22;10(7):696-706. doi: 10.18632/oncotarget.26511. eCollection 2019 Jan 22.

9.

Inherited selective cobalamin malabsorption in Komondor dogs associated with a CUBN splice site variant.

Fyfe JC, Hemker SL, Frampton A, Raj K, Nagy PL, Gibbon KJ, Giger U.

BMC Vet Res. 2018 Dec 27;14(1):418. doi: 10.1186/s12917-018-1752-1.

10.

Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma.

Gall TMH, Belete S, Khanderia E, Frampton AE, Jiao LR.

Am J Pathol. 2019 Jan;189(1):71-81. doi: 10.1016/j.ajpath.2018.03.020. Review.

PMID:
30558725
11.

Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma.

Meijer LL, Garajová I, Caparello C, Le Large TYS, Frampton AE, Vasile E, Funel N, Kazemier G, Giovannetti E.

Ann Surg. 2018 Dec 9. doi: 10.1097/SLA.0000000000003084. [Epub ahead of print]

PMID:
30394883
12.

TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression.

Ottaviani S, Stebbing J, Frampton AE, Zagorac S, Krell J, de Giorgio A, Trabulo SM, Nguyen VTM, Magnani L, Feng H, Giovannetti E, Funel N, Gress TM, Jiao LR, Lombardo Y, Lemoine NR, Heeschen C, Castellano L.

Nat Commun. 2018 May 10;9(1):1845. doi: 10.1038/s41467-018-03962-x. Erratum in: Nat Commun. 2019 Aug 14;10(1):3738.

13.

Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden.

Frampton AE, Prado MM, López-Jiménez E, Fajardo-Puerta AB, Jawad ZAR, Lawton P, Giovannetti E, Habib NA, Castellano L, Stebbing J, Krell J, Jiao LR.

Oncotarget. 2018 Apr 10;9(27):19006-19013. doi: 10.18632/oncotarget.24873. eCollection 2018 Apr 10.

14.

A systematic review of gallstone sigmoid ileus management.

Farkas N, Kaur V, Shanmuganandan A, Black J, Redon C, Frampton AE, West N.

Ann Med Surg (Lond). 2018 Jan 31;27:32-39. doi: 10.1016/j.amsu.2018.01.004. eCollection 2018 Mar. Review.

15.

The density of mast cells c-Kit+ and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer patients.

Ammendola M, Gadaleta CD, Frampton AE, Piardi T, Memeo R, Zuccalà V, Luposella M, Patruno R, Zizzo N, Gadaleta P, Pessaux P, Sacco R, Sammarco G, Ranieri G.

Oncotarget. 2017 Jul 31;8(41):70463-70471. doi: 10.18632/oncotarget.19716. eCollection 2017 Sep 19.

16.

miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.

Puik JR, Meijer LL, Le Large TY, Prado MM, Frampton AE, Kazemier G, Giovannetti E.

Pharmacogenomics. 2017 Sep;18(14):1343-1358. doi: 10.2217/pgs-2017-0010. Epub 2017 Aug 23. Review.

PMID:
28832247
17.

Using real-time, anonymous staff feedback to improve staff experience and engagement.

Frampton A, Fox F, Hollowood A, Northstone K, Margelyte R, Smith-Clarke S, Redwood S.

BMJ Qual Improv Rep. 2017 Apr 28;6(1). pii: u220946.w7041. doi: 10.1136/bmjquality.u220946.w7041. eCollection 2017.

18.

Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.

Giovannetti E, van der Borden CL, Frampton AE, Ali A, Firuzi O, Peters GJ.

Semin Cancer Biol. 2017 Jun;44:43-59. doi: 10.1016/j.semcancer.2017.04.006. Epub 2017 Apr 22. Review.

19.

Contaminated area instability along Ångermanälven River, northern Sweden.

Ströberg A, Ebert K, Jarsjö J, Frampton A.

Environ Monit Assess. 2017 Mar;189(3):118. doi: 10.1007/s10661-017-5839-0. Epub 2017 Feb 20.

20.

Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR.

Castellano L, Dabrowska A, Pellegrino L, Ottaviani S, Cathcart P, Frampton AE, Krell J, Stebbing J.

Nucleic Acids Res. 2017 May 5;45(8):4401-4412. doi: 10.1093/nar/gkx022.

21.

Glycoconjugated Site-Selective DNA-Methylating Agent Targeting Glucose Transporters on Glioma Cells.

Buchanan MK, Needham CN, Neill NE, White MC, Kelly CB, Mastro-Kishton K, Chauvigne-Hines LM, Goodwin TJ, McIver AL, Bartolotti LJ, Frampton AR, Bourdelais AJ, Varadarajan S.

Biochemistry. 2017 Jan 17;56(2):421-440. doi: 10.1021/acs.biochem.6b01075. Epub 2017 Jan 3.

PMID:
28000448
22.

Investigating miRNA-mRNA regulatory networks using crosslinking immunoprecipitation methods for biomarker and target discovery in cancer.

Mato Prado M, Frampton AE, Giovannetti E, Stebbing J, Castellano L, Krell J.

Expert Rev Mol Diagn. 2016 Nov;16(11):1155-1162. Epub 2016 Oct 27. Review.

PMID:
27784183
23.

Equine herpesvirus type 1 modulates inflammatory host immune response genes in equine endothelial cells.

Johnstone S, Barsova J, Campos I, Frampton AR.

Vet Microbiol. 2016 Aug 30;192:52-59. doi: 10.1016/j.vetmic.2016.06.012. Epub 2016 Jun 25.

PMID:
27527764
24.

MicroRNAs associated with small bowel neuroendocrine tumours and their metastases.

Miller HC, Frampton AE, Malczewska A, Ottaviani S, Stronach EA, Flora R, Kaemmerer D, Schwach G, Pfragner R, Faiz O, Kos-Kudła B, Hanna GB, Stebbing J, Castellano L, Frilling A.

Endocr Relat Cancer. 2016 Sep;23(9):711-26. doi: 10.1530/ERC-16-0044. Epub 2016 Jun 27.

25.

Oncological Outcomes of Major Liver Resection Following Portal Vein Embolization: A Systematic Review and Meta-analysis.

Giglio MC, Giakoustidis A, Draz A, Jawad ZAR, Pai M, Habib NA, Tait P, Frampton AE, Jiao LR.

Ann Surg Oncol. 2016 Oct;23(11):3709-3717. doi: 10.1245/s10434-016-5264-6. Epub 2016 Jun 8. Review.

26.

Bioinformatic analysis reveals pancreatic cancer molecular subtypes specific to the tumor and the microenvironment.

Le Large TY, Mato Prado M, Krell J, Bijlsma MF, Meijer LL, Kazemier G, Frampton AE, Giovannetti E.

Expert Rev Mol Diagn. 2016 Jul;16(7):733-6. doi: 10.1080/14737159.2016.1175940. Epub 2016 Apr 27. Review.

PMID:
27118062
27.

Prospective validation of microRNA signatures for detecting pancreatic malignant transformation in endoscopic-ultrasound guided fine-needle aspiration biopsies.

Frampton AE, Krell J, Prado MM, Gall TM, Abbassi-Ghadi N, Del Vecchio Blanco G, Funel N, Giovannetti E, Castellano L, Basyouny M, Habib NA, Kaltsidis H, Vlavianos P, Stebbing J, Jiao LR.

Oncotarget. 2016 May 10;7(19):28556-69. doi: 10.18632/oncotarget.8699.

28.

Gene of the month: HGF.

Fajardo-Puerta AB, Mato Prado M, Frampton AE, Jiao LR.

J Clin Pathol. 2016 Jul;69(7):575-9. doi: 10.1136/jclinpath-2015-203575. Epub 2016 Apr 12. Review.

29.

miR-515-5p controls cancer cell migration through MARK4 regulation.

Pardo OE, Castellano L, Munro CE, Hu Y, Mauri F, Krell J, Lara R, Pinho FG, Choudhury T, Frampton AE, Pellegrino L, Pshezhetskiy D, Wang Y, Waxman J, Seckl MJ, Stebbing J.

EMBO Rep. 2016 Apr;17(4):570-84. doi: 10.15252/embr.201540970. Epub 2016 Feb 10.

30.

Are we following an algorithm for managing chronic anal fissure? A completed audit cycle.

Farkas N, Solanki K, Frampton AE, Black J, Gupta A, West NJ.

Ann Med Surg (Lond). 2015 Nov 25;5:38-44. doi: 10.1016/j.amsu.2015.11.008. eCollection 2016 Feb.

31.

TP53 regulates miRNA association with AGO2 to remodel the miRNA-mRNA interaction network.

Krell J, Stebbing J, Carissimi C, Dabrowska AF, de Giorgio A, Frampton AE, Harding V, Fulci V, Macino G, Colombo T, Castellano L.

Genome Res. 2016 Mar;26(3):331-41. doi: 10.1101/gr.191759.115. Epub 2015 Dec 23.

32.

International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer.

Takaori K, Bassi C, Biankin A, Brunner TB, Cataldo I, Campbell F, Cunningham D, Falconi M, Frampton AE, Furuse J, Giovannini M, Jackson R, Nakamura A, Nealon W, Neoptolemos JP, Real FX, Scarpa A, Sclafani F, Windsor JA, Yamaguchi K, Wolfgang C, Johnson CD; IAP/EPC study group on the clinical managements of pancreatic cancer.

Pancreatology. 2016 Jan-Feb;16(1):14-27. doi: 10.1016/j.pan.2015.10.013. Epub 2015 Nov 12. Review.

PMID:
26699808
33.

MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy.

Garajová I, Funel N, Fiorentino M, Agostini V, Ferracin M, Negrini M, Frassineti GL, Gavelli G, Frampton AE, Biasco G, Giovannetti E.

Clin Epigenetics. 2015 Dec 16;7:129. doi: 10.1186/s13148-015-0162-5. eCollection 2015.

34.

Impact of anxiety and depressive symptoms on perceptions of stigma in persons living with HIV disease in rural versus urban North Carolina.

Costelloe S, Kemppainen J, Brion J, MacKain S, Reid P, Frampton A, Rigsbee E.

AIDS Care. 2015;27(12):1425-8. doi: 10.1080/09540121.2015.1114993. Epub 2015 Dec 7.

PMID:
26643581
35.

Single-cell sequencing in cancer research.

Mato Prado M, Frampton AE, Stebbing J, Krell J.

Expert Rev Mol Diagn. 2016;16(1):1-5. doi: 10.1586/14737159.2016.1115345. Epub 2015 Nov 23.

PMID:
26594792
36.

Circulating microRNAs as diagnostic biomarkers for pancreatic cancer.

Le Large TY, Meijer LL, Prado MM, Kazemier G, Frampton AE, Giovannetti E.

Expert Rev Mol Diagn. 2015;15(12):1525-9. doi: 10.1586/14737159.2015.1112273. Epub 2015 Nov 15.

PMID:
26567751
37.

A global sensitivity analysis of two-phase flow between fractured crystalline rock and bentonite with application to spent nuclear fuel disposal.

Dessirier B, Frampton A, Jarsjö J.

J Contam Hydrol. 2015 Nov;182:25-35. doi: 10.1016/j.jconhyd.2015.07.006. Epub 2015 Aug 4.

38.

Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progression.

Frampton AE, Castellano L, Colombo T, Giovannetti E, Krell J, Jacob J, Pellegrino L, Roca-Alonso L, Funel N, Gall TM, Ahmad R, Habib NA, Knösel T, Stebbing J, Jiao LR.

Lancet. 2015 Feb 26;385 Suppl 1:S37. doi: 10.1016/S0140-6736(15)60352-X.

PMID:
26312859
39.

The role of TP53 in miRNA loading onto AGO2 and in remodelling the miRNA-mRNA interaction network.

Krell J, Stebbing J, Frampton AE, Carissimi C, Harding V, De Giorgio A, Fulci V, Macino G, Colombo T, Castellano L.

Lancet. 2015 Feb 26;385 Suppl 1:S15. doi: 10.1016/S0140-6736(15)60330-0.

PMID:
26312837
40.

Gene of the month: NANOG.

Mato Prado M, Frampton AE, Stebbing J, Krell J.

J Clin Pathol. 2015 Oct;68(10):763-5. doi: 10.1136/jclinpath-2015-203238. Epub 2015 Jul 27. Review. No abstract available.

PMID:
26216907
41.

microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis.

Frampton AE, Krell J, Jamieson NB, Gall TM, Giovannetti E, Funel N, Mato Prado M, Krell D, Habib NA, Castellano L, Jiao LR, Stebbing J.

Eur J Cancer. 2015 Jul;51(11):1389-404. doi: 10.1016/j.ejca.2015.04.006. Epub 2015 May 19. Review.

PMID:
26002251
42.

Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis.

Roca-Alonso L, Castellano L, Mills A, Dabrowska AF, Sikkel MB, Pellegrino L, Jacob J, Frampton AE, Krell J, Coombes RC, Harding SE, Lyon AR, Stebbing J.

Cell Death Dis. 2015 May 7;6:e1754. doi: 10.1038/cddis.2015.89.

43.

Usefulness of Measuring microRNAs in Bile and Plasma for Pancreatic Ductal Adenocarcinoma Diagnosis.

Le Large TY, Frampton AE, Meijer LL, Stebbing J, Kazemier G, Giovannetti E.

Am J Gastroenterol. 2015 May;110(5):768-9. doi: 10.1038/ajg.2015.77. No abstract available.

PMID:
25942302
44.

Activating mutations of GNAS and KRAS in cystic fluid can help detect intraductal papillary mucinous neoplasms of the pancreas.

Frampton AE, Stebbing J, Gall TM, Silver B, Jiao LR, Krell J.

Expert Rev Mol Diagn. 2015 Mar;15(3):325-8. doi: 10.1586/14737159.2015.1002771. Epub 2015 Feb 6.

PMID:
25656048
45.

Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway.

Alshaker H, Krell J, Frampton AE, Waxman J, Blyuss O, Zaikin A, Winkler M, Stebbing J, Yagüe E, Pchejetski D.

Breast Cancer Res. 2014 Oct 25;16(5):426. doi: 10.1186/s13058-014-0426-6.

46.

Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer.

Alshaker H, Wang Q, Frampton AE, Krell J, Waxman J, Winkler M, Stebbing J, Cooper C, Yagüe E, Pchejetski D.

Breast Cancer Res Treat. 2015 Jan;149(1):59-67. doi: 10.1007/s10549-014-3228-8. Epub 2014 Dec 7.

PMID:
25481644
47.

A Study of Clinical Coding Accuracy in Surgery: Implications for the Use of Administrative Big Data for Outcomes Management.

Nouraei SA, Hudovsky A, Frampton AE, Mufti U, White NB, Wathen CG, Sandhu GS, Darzi A.

Ann Surg. 2015 Jun;261(6):1096-107. doi: 10.1097/SLA.0000000000000851.

PMID:
25470740
48.

The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach.

Badreldin W, Krell J, Chowdhury S, Harland SJ, Mazhar D, Harding V, Frampton AE, Wilson P, Berney D, Stebbing J, Shamash J.

BJU Int. 2016 Mar;117(3):418-23. doi: 10.1111/bju.13004. Epub 2015 Jun 13.

49.

Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer.

Garajová I, Le Large TY, Frampton AE, Rolfo C, Voortman J, Giovannetti E.

Biomed Res Int. 2014;2014:678401. doi: 10.1155/2014/678401. Epub 2014 Aug 28. Review.

50.

miR-211 modulates gemcitabine activity through downregulation of ribonucleotide reductase and inhibits the invasive behavior of pancreatic cancer cells.

Maftouh M, Avan A, Funel N, Frampton AE, Fiuji H, Pelliccioni S, Castellano L, Galla V, Peters GJ, Giovannetti E.

Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):384-93. doi: 10.1080/15257770.2014.891741.

PMID:
24940696

Supplemental Content

Loading ...
Support Center